More about

Ovarian Cancer

News
March 21, 2022
1 min read
Save

Artificial intelligence model predicts treatment response in ovarian cancer

Artificial intelligence model predicts treatment response in ovarian cancer

A trained artificial intelligence model predicted treatment outcomes before surgery of women with high-grade serous ovarian cancer, according to study results.

News
March 21, 2022
2 min read
Save

Q&A: Researchers find genetic link between endometriosis, ovarian cancer

Q&A: Researchers find genetic link between endometriosis, ovarian cancer

Data published in Cell Reports Medicine showed that endometriosis was genetically linked to ovarian cancer.

News
March 16, 2022
2 min read
Save

32% of older women who survived certain cancers report lower extremity lymphedema

32% of older women who survived certain cancers report lower extremity lymphedema

Nearly one-third of older women who survived colorectal, endometrial or ovarian cancer reported lower extremity lymphedema, according to data published in JAMA Network Open.

News
March 10, 2022
3 min read
Save

Hyperthermic intraperitoneal chemotherapy may benefit some women with ovarian cancer

Hyperthermic intraperitoneal chemotherapy may benefit some women with ovarian cancer

Adding hyperthermic intraperitoneal chemotherapy to cytoreductive surgery did not significantly prolong PFS or OS among women with advanced epithelial ovarian cancer, according to a single-blind, randomized study in JAMA Surgery.

News
March 10, 2022
2 min read
Save

Paclitaxel plus carboplatin ’preferred regimen of choice’ for gynecologic carcinosarcomas

Paclitaxel plus carboplatin ’preferred regimen of choice’ for gynecologic carcinosarcomas

Paclitaxel plus carboplatin demonstrated noninferiority to paclitaxel plus ifosfamide and should be a standard treatment for uterine carcinosarcoma, according to results of a phase 3 study published in Journal of Clinical Oncology.

News
March 09, 2022
2 min read
Save

Germline BRCA testing underused for women with ovarian cancer and commercial insurance

Germline <i>BRCA</i> testing underused for women with ovarian cancer and commercial insurance

About one-third of women with commercial insurance underwent genetic testing for ovarian cancer between 2008 and 2018 despite unequivocal recommendations for universal testing, according to research in JAMA Network Open.

News
January 14, 2022
2 min read
Save

High platelet count associated with increased risk for certain cancers

High platelet count associated with increased risk for certain cancers

Individuals with an increased platelet count demonstrated an increased risk for cancer, with the association especially strong in colon, lung, ovarian and stomach cancers, according to a nested case-control study in JAMA Network Open.

News
December 29, 2021
2 min read
Save

2021’s top stories about breast, cervical and ovarian cancer research

2021&rsquo;s top stories about breast, cervical and ovarian cancer research

COVID-19 dominated headlines in 2021, but breast, cervical and ovarian cancers remain leading causes of mortality among women. Here are our top stories about new research designed to save lives for the year.

News
December 09, 2021
1 min read
Save

Top in hem/onc: Cash balance plans, physician-patient relationships

Top in hem/onc: Cash balance plans, physician-patient relationships

The pension plan known as a cash balance plan may help physicians reduce their practices’ and their own taxable income. A review of how this plan works and its potential benefits was the top story in hematology/oncology last week.

News
December 02, 2021
2 min read
Save

Cytoreductive surgery before chemotherapy benefits women with recurrent ovarian cancer

Cytoreductive surgery before chemotherapy benefits women with recurrent ovarian cancer

Cytoreductive surgery before chemotherapy led to significant and clinically meaningful OS and PFS benefits for women with recurrent ovarian cancer, according to a phase 3 study published in The New England Journal of Medicine.

View more